Axsome Therapeutics, Inc. (AXSM)
NASDAQ·Healthcare·Biotechnology
$228.53
-2.37%
Mkt Cap $12.40B
Analyst Ratings
Buy
22
Hold
1
Sell
0
Price Target (71 analysts)
$262.38
Range $200.00 – $380.00
Implied Upside
+14.8%
Consensus $262.38 vs current $228.53